跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Phebra SODIUM BICARBONATE 8.4% w/v 840 mg/10 mL injection BP vial - TGA Drug Approval Details
Approvals
/
TGA
/
Phebra SODIUM BICARBONATE 8.4% w/v 840 mg/10 mL injection BP vial
Approved
STANDARD
Phebra SODIUM BICARBONATE 8.4% w/v 840 mg/10 mL injection BP vial
Phebra Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
4f2703ed18fec99f
Company
Phebra Pty Ltd
Type
Standard
Approval Details
Approval Id
4f2703ed18fec99f
Product Name
Phebra SODIUM BICARBONATE 8.4% w/v 840 mg/10 mL injection BP vial
Artg Id
131067
Artg Name
Phebra SODIUM BICARBONATE 8.4% w/v 840 mg/10 mL injection BP vial
Sponsor
Phebra Pty Ltd
Company Detail Path
/organization/phebra-pty-ltd
Artg Date
2007-02-02
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/1c472e6c0cff98380135d3987f72c445.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/262d81adae0a7da73351452443017155.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
4f2703ed18fec99f
Type
Standard
Back to TGA Approvals